MetaCap

Cencora (COR) vs DataMeds AI (MEDS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cencora is the larger company by market cap ($64.71 billion vs $7.7 million), about 8435.0 times the size, while DataMeds AI is growing revenue faster (+28.7% vs +9.3%). Cencora pays a dividend yielding 0.71%, while DataMeds AI does not currently pay one. Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -433.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

COR+6.88%MEDS-53.47%
+23%-30%-83%
Oct 7, 20261 yearNov 20, 2026
COR+4.71%MEDS-54.73%
+15%-32%-79%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

COR versus MEDS key metrics
MetricCORMEDS
Share price$339.09$1.34
Market cap$64.71B$7.67M
1-day change-0.63%+84.14%
YTD return+0.40%—
1-year return-7.27%—
5-year return+182.03%—
P/E ratio (TTM)18.89—
Forward P/E15.60—
EPS (TTM)$17.95$-18.39
Dividend yield0.71%0.00%
Annual dividend$2.40$0.00
Revenue (latest FY)$321.33B$23.34M
Revenue growth (YoY)+9.31%+28.73%
Net income (latest FY)$1.55B$-101.27M
Gross margin3.57%-27.54%
Operating margin0.82%-401.70%
Net margin0.48%-433.95%
52-week high$377.54$33.15
52-week low$244.82$0.493
Distance from 52-week high-10.18%-95.96%
Analyst consensusbuy—
Avg. price target upside+12.78%—
Average volume1.29M8.43M
Shares outstanding190.83M5.72M
Employees47,000—
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cencora is about 8435.0 times larger than DataMeds AI by market value ($64.71B vs $7.67M).
  • Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -433.9 cents for DataMeds AI.
  • DataMeds AI grew revenue faster in its latest fiscal year (+28.73% vs +9.31%).

About Cencora

COR stock →

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

Health Care · Other Pharmaceuticals · 47,000 employees

About DataMeds AI

MEDS stock →

DataMEDS AI, Inc. operates as a health IT company in the United States.

Health Care · Other Pharmaceuticals

COR vs MEDS FAQ

Which is bigger, Cencora or DataMeds AI?

Cencora (COR) is larger, with a market capitalization of $64.71B compared with $7.67M for DataMeds AI (MEDS).

Which pays a higher dividend, Cencora or DataMeds AI?

Cencora pays a dividend yielding 0.71%, while DataMeds AI does not currently pay a regular dividend.

Are Cencora and DataMeds AI in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons